Ovoca Bio Company Review & Valuation

OVXA
Euronext Dublin
Latest Price
0.14EUR
Market Capitalization
11.01mEUR

About Ovoca Bio plc

Ovoca Bio plc focuses on development and commercialization of novel product candidates for the treatment of female sexual dysfunctions.

It is developing Libicore, a medication for treatment of female sexual dysfunction.

The company was formerly known as Ovoca Gold plc and changed its name to Ovoca Bio plc in July 2018.

Ovoca Bio plc was founded in 1985 and is based in Dublin, Ireland.

Industry
Biotechnology
HQ Location
Dublin, Ireland

Stock Price

Price data not available for Ovoca Bio.

Performance

Please login or create a free account to view the contents of this section.

Financial Reports

Please login or create a free account to view the contents of this section.

Similar Companies

back to top

Valuu.io

Valuu provides insights and tools for self-directed stock investors. It enables you to easily find, valuate and track your stock investments with the help of reliable financial data and transparent analysis tools.

Disclaimer: This website is a data portal, which aggregates information about public companies. It is not a stock broker and does not give advice concerning specific investment decisions or tax or legal advice. All data is provided "as-is" with no guarantee for correctness and/or completeness. All company names, logos, and brands are intellectual property of their respective owners. The use of them is for editorial purposes only and does not imply any affiliation or endorsement.
© 2019-2021 Valuu Analytics Sàrl